Metabolism of exercising skeletal muscle during beta 1-selective adrenoceptor blockade. 1986

O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen

Concentrations of glycogen, glucose, glucose-6-phosphate and lactate in the lateral vastus muscle were measured in seven subjects before and after dynamic muscle exercise at a work load of 75% of each subject's maximal working capacity, and with and without intravenous administration of the beta 1-selective beta-adrenoceptor blocking agent, atenolol. Pulmonary oxygen uptake was measured during exercise. Heart rate and arterial blood pressure were measured throughout the study. Arterial concentrations of glucose, lactate and free fatty acids were measured at rest and during exercise. The muscle concentration of glycogen and the extent of glycogen depletion with exercise were not influenced by the beta 1-adrenoceptor blocker. Similarly, there was no change in the muscle concentrations of glucose, glucose-6-phosphate and lactate. Heart rate decreased at rest and during exercise. Arterial blood pressure was not influenced by beta-blockade. Pulmonary oxygen uptake decreased by 6.5%. The exercise induced rise in arterial blood concentration of free fatty acids was abolished by beta 1-selective beta-blockade. It is concluded that the decrease in lactate release from exercising muscles during beta 1-adrenoceptor blockade seen in other studies cannot be explained by an impaired breakdown of muscle glycogen. It may be inferred, however, that a reduced availability of free fatty acids in the exercising muscles during beta 1-selective (and non-selective) beta-blockade may enhance the combustion of pyruvic acid and thereby decrease the production of lactate.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005958 Glucosephosphates
D006003 Glycogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
January 1995, Journal of applied physiology (Bethesda, Md. : 1985),
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
January 1988, Acta medica Scandinavica,
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
January 1982, Acta medica Scandinavica. Supplementum,
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
January 1985, British journal of clinical pharmacology,
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
January 1987, European journal of applied physiology and occupational physiology,
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
April 1986, Clinical physiology (Oxford, England),
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
May 1994, The Journal of physiology,
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
June 1984, The American journal of cardiology,
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
April 1988, British journal of clinical pharmacology,
O J Hartling, and B Schibye, and K Klausen, and J O Lund, and J Trap-Jensen
May 1986, Clinical science (London, England : 1979),
Copied contents to your clipboard!